Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Gloria Strayhorn, et al v. Wyeth Pharmaceuticals, Inc., et al
Case Number:
12-6195
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
January 24, 2014
6th Circ. Won't Rehear Generic-Reglan Injury Claims
The Sixth Circuit refused to rehear seven lawsuits alleging drug manufacturers should be liable for serious neurological conditions that users incurred after taking a generic version of digestion medication Reglan, finding Thursday that the users' claims have already been considered.
-
December 02, 2013
Generic-Reglan Suits Doomed By Catch-22, 6th Circ. Says
A Sixth Circuit panel on Monday refused to revive seven lawsuits alleging a generic version of digestion medication Reglan caused users to develop a serious neurological condition, ruling the plaintiffs were caught in a catch-22 preventing them from bringing claims against generic or brand-name manufacturers.